School of Medicine, South China University of Technology, Guangzhou, 510006, Guangdong, China.
Department of Colorectal and Stomach Cancer Surgery, Jilin Cancer Hospital, Changchun, 130021, Jilin, China.
J Cancer Res Clin Oncol. 2023 Aug;149(9):5497-5512. doi: 10.1007/s00432-022-04498-w. Epub 2022 Dec 5.
To demonstrate the biological function of Secreted Phosphoprotein 1(SPP1) and its immune suppressive role in the progression intrahepatic cholangiocarcinoma (ICC).
We collected 62,770 cells' published transcriptome data of nine patients whose paired adjacent liver and tumor tissues were both available. We applied differential gene expression analysis to screen potential ICC marker genes, survival analysis to verify the prognostic value of SPP1, and correlation analysis to decipher factors that are related to SPP1 expression. The CellChat was used to distinguish interactions between cancer and T cells. CytoSig was applied to query cytokines that modulate CD44. Further, we established a proliferation score and correlated the score with inhibitory signals to determine the proliferation-suppressive function of SPP1-CD44.
SPP1 expression is significantly upregulated in tumoral epitheliums, and patients with higher SPP1 expression have worse survival (P < 0.05). Tumor cells communicate with T cells via SPP1-CD44 interactions. The average expression of SPP1 in malignant cells (SPP1m) and CD44 in T cells (CD44t) is moderately negatively correlated with T cell proliferation score. Immunosuppressive cytokine TGFβ-3 identified as an inducer of CD44 and was significantly negatively correlated with proliferation score (R = - 0.88, P < 0.01), and the negative correlation was aggravated in samples with high CD44 expression.
SPP1 is a prognostic marker of ICC and is associated with the genome heterogeneity. SPP1-CD44 hinders sustained proliferation of T cells, but immunosuppressive T cells in the tumor microenvironment may evade this inhibition by reducing CD44 expression.
展示分泌磷蛋白 1(SPP1)的生物学功能及其在肝内胆管癌(ICC)进展中的免疫抑制作用。
我们收集了 9 名患者的 62770 个细胞发表的转录组数据,这些患者的配对相邻肝组织和肿瘤组织均可用。我们应用差异基因表达分析筛选潜在的 ICC 标记基因,生存分析验证 SPP1 的预后价值,以及相关分析破译与 SPP1 表达相关的因素。使用 CellChat 区分癌症和 T 细胞之间的相互作用。应用 CytoSig 查询调节 CD44 的细胞因子。此外,我们建立了一个增殖评分,并将评分与抑制信号相关联,以确定 SPP1-CD44 的增殖抑制功能。
SPP1 在肿瘤上皮中的表达显著上调,表达水平较高的患者生存较差(P<0.05)。肿瘤细胞通过 SPP1-CD44 相互作用与 T 细胞通讯。恶性细胞中 SPP1 的平均表达(SPP1m)和 T 细胞中 CD44 的平均表达(CD44t)与 T 细胞增殖评分呈中度负相关。鉴定为 CD44 诱导剂的免疫抑制性细胞因子 TGFβ-3 与增殖评分呈显著负相关(R=-0.88,P<0.01),并且在 CD44 表达较高的样本中,这种负相关加剧。
SPP1 是 ICC 的预后标志物,与基因组异质性相关。SPP1-CD44 阻碍 T 细胞的持续增殖,但肿瘤微环境中的免疫抑制性 T 细胞可能通过降低 CD44 表达来逃避这种抑制。